Cargando…
Inhibition of SARS-CoV-2 Infection by Human Defensin HNP1 and Retrocyclin RC-101
Severe acute respiratory syndrome coronavirus (SARS-CoV)-2 is an enveloped virus responsible for the COVID-19 pandemic. The emergence of new potentially more transmissible and vaccine-resistant variants of SARS-CoV-2 is an ever-present threat. Thus, it remains essential to better understand innate i...
Autores principales: | Kudryashova, Elena, Zani, Ashley, Vilmen, Geraldine, Sharma, Amit, Lu, Wuyuan, Yount, Jacob S., Kudryashov, Dmitri S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413479/ https://www.ncbi.nlm.nih.gov/pubmed/34487793 http://dx.doi.org/10.1016/j.jmb.2021.167225 |
Ejemplares similares
-
Defensins versus pathogens: an unfolding story
por: Kudryashova, Elena, et al.
Publicado: (2015) -
The θ‐defensin retrocyclin 101 inhibits TLR4‐ and TLR2‐dependent signaling and protects mice against influenza infection
por: Prantner, Daniel, et al.
Publicado: (2017) -
Preformulation and stability in biological fluids of the retrocyclin RC-101, a potential anti-HIV topical microbicide
por: Sassi, Alexandra B, et al.
Publicado: (2011) -
Thermodynamic instability of viral proteins is a pathogen-associated molecular pattern targeted by human defensins
por: Kudryashova, Elena, et al.
Publicado: (2016) -
Reawakening Retrocyclins: Ancestral Human Defensins Active Against HIV-1
por: Venkataraman, Nitya, et al.
Publicado: (2009)